Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I0SY
|
||||
| Former ID |
DIB001164
|
||||
| Drug Name |
MEDI-542
|
||||
| Synonyms |
Ephrin a4-targeting monoclonal antibody (cancer), MedImmune
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Terminated | [548047] | ||
| Company |
Medlmmune LLC
|
||||
| Target and Pathway | |||||
| Target(s) | Epha4 tyrosine kinase receptor | Target Info | [551569] | ||
| KEGG Pathway | Axon guidance | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | EphrinA-EPHA pathway | ||||
| EPHA forward signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.